Introduction {#Sec1}
============

Academic science is big business and big money. Billions of US-dollars (USD), Euros and other currencies are channeled into academic science every year. As a matter of fact, the decision makers---politicians and career officials---want to know about the fate of funding: Did it work? What was done? How much was done? Who did it? Who did the most?

In order to answer these questions, the field of scientometrics and bibliometric offer convenient but debated benchmarking parameters including the impact factor of a scientific journal. Since the journal impact factor is a very superficial measure with no direct relation to the quality of a single scientific work (Carey [@CR37]; Casadevall and Fang [@CR39]) but only providing information about the performance of a specific journal over a relatively short term, other more sophisticated parameters were developed such as the Hirsch (H) index (Hirsch [@CR87], [@CR88]). They also include a count of the individual citations that a scientific article receives. However, also the H-index is debatable and should not to be used for any purpose (Bertoli-Barsotti and Lando [@CR9], [@CR10]; Bornmann and Leydesdorff [@CR17]). In this respect, experts in the field have coined the expression of amateur bibliometricians describing the uncritical use of bibliometric tools (Bornmann and Leydesdorff [@CR16]).

With these benchmarking options at hand, other questions arise for decision makers: Can we allocate the funding towards a direction that those who did most---get more funding in order to increase their productivity? To which extend can we do so? Is there a ceiling effect? I.e. by which extend is the total (not relative) productivity increased, if we allocate 2 staff positions to a research group which consist of 2 scientists (making a total of 4 scientists then) in comparison to the allocation of 2 staff positions to a group consisting of 20 scientists or of 50 scientists (making it 22 or 52, respectively). Measured in citations? Or in accumulated impact factors or whatsoever? These questions are linked to the so called Matthew effect (Merton [@CR114]): Those who have most get even more. When counting, measuring and benchmarking are done by the use of superficial parameters in an uncritical way by amateur bibliometricians, and (intramural and extramural) funding is allocated on the basis of who performs best in those superficial counts (i.e. total accumulated impact factor count) these questions critically target freedom of research: Scientists or fields who do not produce measurable amounts of superficial parameters such as accumulated journal impact factors will suffer (Lowy [@CR109]).

Further to the question of funding allocation, also career opportunities are critically dependent on bibliometric benchmarking processes and it is common (but critically debated) law: publish or perish (in high impact factor journals) (Jokstad [@CR93]; Publish or perish [@CR130]; Bergquist et al. [@CR7]). Taking these aspects into account, it is obvious that scientometric markers need to be used only with great caution. They should not be easily used to compare scientists of different ages and different fields, institutions or areas with the purpose to cut off funding since research should only be interpreted for quality on the individual level of a published piece of work.

Still, bibliometric parameters can be used to assess gross information contents and evolution of scientific fields over longer periods of time.

It was exactly this purpose when in the years 2005--2009 a new project was started at the Charité in Berlin (Borger et al. [@CR15]; Groneberg-Kloft et al. [@CR80], [@CR84], [@CR76], [@CR82], [@CR83]): A platform termed NewQIS (1.0) was constructed to establish a new approach to visualize research quantity and quality indices (Groneberg-Kloft et al. [@CR77], [@CR81]). NewQIS 1.0 should be used to assess research activities for (1) distinct areas of science, for (2) single institutions, for (3) single countries, or for (4) single time periods (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1The NewQIS platform can visualize research parameters for **a** different areas of science, for **b** different institutions, for **c** different countries, or for **d** different periods of time. A multitude of parameters can be assessed

The platform was intended to be a sound basis for future NewQIS studies in all areas of medicine and science. In the following, we (a) briefly summarize the technical basis, and (b) present an overview of the studies and MD theses which were performed on the basis of NewQIS.

Technical platform {#Sec2}
------------------

One important aspect of NewQIS 1.0 was to establish a unified technical platform that enables researchers from different fields of science to be able to assess their area of interest. Therefore, a study panel was formed that decided upon the feasibility of the proposed area. The usual applicants were medical students who---in their duty to conduct an MD thesis---submitted search topics to the study panel. After review and affirmation, the NewQIS analysis were performed and raw data was transferred to the applicants for their purpose.

### Data acquisition {#Sec3}

In NewQIS studies, data is usually retrieved from the Web of Science (WoS) database, i.e. (Kusma et al. [@CR105]). The reason to choose WoS was the ability to perform a citation analysis. This was not possible with PubMed data files.

Depending on the topic of the NewQIS study, the search terms that are entered in the search field consist of various terms which are linked together with Boolean operators such as "AND", "OR", "NOT", i.e. (Glynn et al. [@CR59]).

Depending on the date of the research, the amount of publications and the focus of the research, the evaluation time span covers periods from 1900 until today. Usually, the year in which the NewQIS project is performed, is left out because of incomplete data acquisitions for that given year, i.e. (Al-Mutawakel et al. [@CR6]).

### Parameters {#Sec4}

The large majority of NewQIS projects focus on a single field of medicine such as a disease and put a focus on the global landscape of research on this particular disease. Thus, the following parameters are usually analyzed (Fig. [1](#Fig1){ref-type="fig"}).

Quantity parameters: ProductivityTotal number of published items (i.e. Scutaru et al. [@CR160])Country specific number of publishes items (i.e. Vitzthum et al. [@CR172])

(Semi-)qualitative parameters: Usually, high quality research is characterized by a high number of citations. Therefore, the following citation parameters were also analyzed in the NewQIS projects:Total number of citationsTotal number of citations per countryCountry-specific h indexCountry-specific average citation rate per article

Cooperation parameters: A key instrument of NewQIS is to visualize different levels of collaboration. This includes either collaborations between single scientists, countries or institutions. The field of RSV (respiratory syncytial virus) research can give an example how this is achieved: After having identified all relevant RSV-associated publications, the collaborative studies were related to their countries of origin. Publications with two or more authors affiliated to the same country were counted only once for the total number of collaborations of this particular country (Bruggmann et al. [@CR26]). If an author had two affiliations, these were counted for every country mentioned in the affiliations. Connecting vectors visualized these co-operations; their width and shade of grey reflected the number of joint publications (Bruggmann et al. [@CR26]). Figure [2](#Fig2){ref-type="fig"} illustrates international collaborations for RSV research.Fig. 2International collaborations for RSV research. International cooperations on RSV research (threshold \> 2 cooperations). Numbers in brackets report the number of publications in total/collaborative publications.<https://bmjopen.bmj.com/content/7/7/e013615.long>, Data from Bruggmann et al. ([@CR26])

### Visualization {#Sec5}

The above listed parameters can also be found in other publications using other approaches (Burak Atci et al. [@CR35]; Ekundayo and Okoh [@CR42]). A specific purpose of NewQIS was to combine these bibliometric parameters with visualization techniques in order to provide a picture of the global landscape of different research aspects. Among different available techniques, density-equalizing map projections (DEMP) were chosen. As elegantly described by Gastner and Newman, map makers searched for a long a way to generate cartograms, in which the sizes of countries appear in proportion to a chosen parameter such as their population (Gastner and Newman [@CR51]). For the purpose of NewQIS, these maps could be used to visualize research activities. As stated by Gastner and Newman, in order to scale countries and still have them properly fit together, they need to be distorted, causing difficulties to read them. In 2004, a new method was proposed which was integrated to the NewQIS platform. With DEMPs being a part of NewQIS, the territories of countries were re-sized according to a particular variable, i.e. in proportion to the countries´ total number of published items regarding to a specific disease. Figure [3](#Fig3){ref-type="fig"} shows examples of DEMPs published within NewQIS studies over the past decade. The distorted global landscape is usually characterized by a dominating USA and an enlarged European area as depicted in Fig. [3](#Fig3){ref-type="fig"}a for pulmonary hypertension research output (Gotting et al. [@CR61]). However, there are also research areas in which also countries from other continental regions appear enlarged. This can be seen for snakebite envenoming research for Brazil as shown in Fig. [3](#Fig3){ref-type="fig"}b (Groneberg et al. [@CR71]). China---a rising star in many areas of science---does also appear in some NewQIS assessments prominently as shown for ovarian cancer research in Fig. [3](#Fig3){ref-type="fig"}c (Bruggmann et al. [@CR30]). Concerning Asian countries, a previous assessment of 5527,558 articles has indicated that Asian countries have largely different research focuses in comparison to Western countries (Groneberg-Kloft et al. [@CR84]). In order to assess changes over the time, spatiotemporal analyses can also be performed by merging to a video consisting of different density-equalizing mapping (Groneberg-Kloft et al. [@CR83]).Fig. 3Density equalizing map projections (DEMP). **a** DEMP for pulmonary hypertension research output. Data from Gotting et al. ([@CR61]). **b** DEMP for snakebite envenoming research output. Data from Groneberg et al. ([@CR71]). **c** DEMP exemplifying prominent Chinese research activities in ovarian cancer research. Data from Bruggmann et al. ([@CR30])

Topics of NewQIS {#Sec6}
----------------

### Structured MD thesis program {#Sec7}

The original concept of NewQIS was a low budget intramural platform which was established without major external funding. In order to be able to assess numerous fields of medicine, medical students were enabled to conduct their MD thesis within the NewQIS platform. The highly structured boundaries of the platform also served as a quality control for the results of the thesis projects making scientific misconduct very difficult (since there was no possibility for the students to manipulate the algorithms applied by the platform).

Since 2009, nearly 80 theses were completed using the methodology of the platform making NewQIS one of the most successful structured thesis programs in Germany. As tutors/mentors of the theses, seven associate/full professors served so far. Also, two technical tutors were present to oversee calculations and data management. Table [1](#Tab1){ref-type="table"} lists the medical thesis topics.Table 1Medical thesis projects that applied the structured NewQIS programNo.Place of thesisYear of examTopic of MD thesisAnalysis intervalReferences1.Frankfurt2019Tunisia1900--2013Fuchs ([@CR49])2.Frankfurt2018Immigration1900--2016Trost ([@CR166])3.Frankfurt2018Cervical cancer1900--2015Quinkert ([@CR134])4.Frankfurt2018Ovarian carcinoma1900--2014Pulch ([@CR132])5.Frankfurt2018Noise1900--2014Brich ([@CR19])6.Frankfurt2018Needle stick injury1900--2014Braumann ([@CR18])7.Frankfurt2018Jaw palate clefts1900--2014Mierke ([@CR115])8.Frankfurt2018Child abuse1900--2014Wolf ([@CR182])9.Frankfurt2018Melanoma1900--2014Scholz ([@CR155])10.Frankfurt2018Rotavirus1900--2013Köster ([@CR99])11.Frankfurt2018Caesarean section1900--2013Löhlein ([@CR108])12.Frankfurt2018Caries1900--2012Kröber ([@CR103])13.Frankfurt2018Tuberculosis1900--2012Weber ([@CR178])14.Frankfurt2018Tonsillectomy1900--2014Neuenfeldt ([@CR121])15.Frankfurt2018Schizophrenia1900--2015Lammer ([@CR106])16.Frankfurt2018Gestational diabetes1900--2012Richter ([@CR136])17.Frankfurt2017Pancreatic carcinoma1900--2013Krempel ([@CR102])18.Frankfurt2017Osteoporosis1900--2012Mäule ([@CR112])19.Frankfurt2017Human papilloma virus1900--2009Kayser ([@CR94])20.Frankfurt2017Cholera1900--2009Mühlbach ([@CR116])21.Frankfurt2016Psychiatric journals1920--2012Abberger ([@CR1])22.Frankfurt2016Gastroenterological journals1945--2012Schäfer ([@CR138])23.Frankfurt2016Public Health1912--2012D. Hoffmann ([@CR90])24.Frankfurt2016Toxoplasmosis1900--2012Handl ([@CR85])25.Frankfurt2015Aortic aneurysm1900--2010Ofosu ([@CR124])26.Berlin2015Depression, suicide, cannabis, bipolar disorder1900--2008Vogelzang ([@CR174])27.Frankfurt2014Yellow fever1900--2012Bundschuh ([@CR33])28.Frankfurt2014Smoking and pregnancy1900--2005Mund ([@CR118])29.Frankfurt2014Propofol1977--2009W. Weiland ([@CR180])30.Frankfurt2014Extrinsic allergic alveolitis1900--2007Walger ([@CR177])31.Frankfurt2013Hepatitis B1900--2010Schmidt ([@CR140])32.Frankfurt2013Osteomyelitis1900--2009Schwartzmann ([@CR157])33.Frankfurt2013Passive smoking1900--2009Jacobus ([@CR92])34.Frankfurt2013Poliomyelitis1900--2009Drews ([@CR41])35.Frankfurt2013Dental implants1900--2010Albrecht ([@CR5])36.Frankfurt2013Influenza1900--2009Fricke ([@CR45])37.Berlin2012Diabetic retinopathy1900--2008Wahrlich ([@CR120])38.Berlin2012Neurologic and psychiatric rehabilitation1900--2009Hoffmann--Roe ([@CR91])39.Frankfurt2012MRI-Scan1981--2006Schwarze ([@CR158])40.Berlin2012Pulmonary hypertension1900--2007Götting ([@CR60])41.Frankfurt2012Allergic rhinitis1900--2007Wende ([@CR181])42.Frankfurt2012Sarcoidosis1900--2008Kirchdörfer ([@CR95])43.Berlin2011Bacterial meningitis1900--2007Pleger ([@CR127])44.Berlin2011Erythropoietin1900--2007Schöffel ([@CR142])45.Berlin2011Bladder cancer1909--2007Domnitz ([@CR40])46.Berlin2011Borrelia burgdorferi 1900--2008Scholz ([@CR154])47.Frankfurt2011Dengue virus infections1900--2007Müller ([@CR117])48.Hannover2011Orthopedic diseases1900--2008Vitzthum ([@CR170])49.Berlin2011Glioblastoma multiforme1900--2008Addicks ([@CR2])50.Berlin2011Infectious endocarditis1900--2008Berkholz ([@CR8])51.Berlin2011Obesity1900--2009Franke ([@CR44])52.Berlin2011Air pollution, particulate matter and sulphur dioxide1955--2006Zell ([@CR183])53.Berlin2011Methicillin-resistant staphylococcus aureus (MRSA)1961--2007Addicks ([@CR3])54.Berlin2011Barotrauma1900--2008Garnew ([@CR50])55.Berlin2011M Alzheimer1985--2006Tropp ([@CR165])56.Berlin2011Varicella zoster virus1900--2008Busch ([@CR36])57.Berlin2011Resuscitation1900--2007Weiland ([@CR179])58.Berlin2011Cystic fibrosis1900--2009Falahkohan ([@CR43])59.Berlin2010Body mass index1900--2008Bohlen ([@CR13])60.Berlin2010Poisonous snake bites1900--2007Geier ([@CR53])61.Berlin2010Myasthenia gravis1900--2008Koch ([@CR98])62.Berlin2010Asbestos1900--2008Kröger ([@CR104])63.Berlin2010Clostridium botulinum1905--2008Uibel ([@CR168])64.Berlin2010Age-related macular degeneration1900--2008Steinberg ([@CR161])65.Berlin2010SARS2003--2007Kreiter ([@CR101])66.Berlin2010Epithelial precursor lesions1900--2008Grajewski ([@CR62])67.Berlin2010Multiple sclerosis1900--2008Hoffmann ([@CR89])68.Berlin2010Herpes simplex virus1900--2007Szerwinski ([@CR164])69.Berlin2009Burnout syndrome1983--2006Fröhlich ([@CR48])70.Berlin2009Drowning accidents1900--2006Schilling ([@CR139])71.Berlin2009Measles1900--2008Rospino ([@CR137])72.Berlin2009Human immunodeficiency virus (HIV) 1982--2007Neye ([@CR122])73.Berlin2009Carpal tunnel syndrome1900--2006Friedebold ([@CR47])74.Berlin2009Streptococcus1957--2006Bock ([@CR12])75.Berlin2009Syphilis1900--2007Bircks ([@CR11])76.Berlin2009Arthrosis1900--2007Mayer ([@CR113])77.Berlin2009Telemedicine1976--2006Rahimian ([@CR135])78.Berlin2009Epilepsy1900--2007Bircks ([@CR11])79.Berlin2009Bronchial asthma1967--2006Puk ([@CR131])

### Scientific publications {#Sec8}

Since 2008, more than 80 studies using the NewQIS platform were published after peer review. The majority of them based on medical thesis projects with the MD students being first authors in case of writing the manuscripts or co-authors of the scientific studies. The topics ranged from infectious diseases, infectious agents, to cancers, neurological or psychiatric disorders, lung diseases or other diseases. Apart from diseases, they also encompassed i.e. public health issues including tobacco control, medical procedures or techniques. In total, more than 1.6 million published articles related to specific search terms were analyzed for the above listed parameters. Table [2](#Tab2){ref-type="table"} provides an overview of the different NewQIS articles.Table 2Scientific publications applying the NewQIS platformNo.AuthorsYearTitleAnalysis intervalTotal number of published itemsReference1.Börger et al.2008Models of asthma: density-equalizing mapping and output benchmarking1900--20063489Borger et al. ([@CR15])2.Groneberg-Kloft et al.2008Institutional operating figures in basic and applied sciences: scientometric analysis of quantitative output benchmarking1966--19761996--20065,527,558Groneberg-Kloft et al. ([@CR84])3.Groneberg-Kloft et al.2009Cough as a symptom and a disease entity: scientometric analysis and density-equalizing calculations1900--200712,960Groneberg-Kloft et al. ([@CR76])4.Groneberg-Kloft et al.2009Inter-disease comparison of research quantity and quality: bronchial asthma and chronic obstructive pulmonary disease1987--2006n.a.Groneberg-Kloft et al. ([@CR82])5.Kusma et al.2009Tobacco control: visualisation of research activity using density-equalizing mapping and scientometric benchmarking procedures1952--20081846Kusma et al. ([@CR105])6.Schöffel et al.2009The role of endocarditis, myocarditis and pericarditis in qualitative and quantitative data analysis1900--200718,967 (endocarditis)7803 (myocarditis)5552 (pericarditis)Schoffel et al. ([@CR152])7.Vitzthum et al.2009Scoliosis: density-equalizing mapping and scientometric analysis1904--2078186Vitzthum et al. ([@CR171])8.Al-Mutawakel et al.2010Scientometric analysis of the world-wide research efforts concerning Leishmaniasis1957--200619,277Al-Mutawakel et al. ([@CR6])9.Bohlen et al.2010Scientometric analysis of the BMI1900--200863,845Bohlen et al. ([@CR14])10.Glynn et al.2010Breast cancer research output, 1945--2008: a bibliometric and density-equalizing analysis1945--2008180,126Glynn et al. ([@CR59])11.Grajewski et al.2010A scientometric analysis of leukoplakia and erythroplakia1900--20082659Grajewski et al. ([@CR63])12.Schöffel et al.2010Reumatoid arthritis: scientific development from a critical point of view1901--200778,128Schoffel et al. ([@CR149])13.Scutaru et al.2010Density-equalizing mapping and scientometric benchmarking of European allergy research2001--2007n.a.Scutaru et al. ([@CR159])14.Schöffel et al.2010Arthroplasty: critical scientometric analysis of current benchmarking and evaluation procedures1901--200721,874Schoffel et al. ([@CR150])15.Scutaru et al.2010Density-equalizing mapping and scientometric benchmarking in Industrial Health1900--2014n.a.Scutaru et al. ([@CR160])16.Schöffel et al.2010Critical analysis of publication procedures and evaluation regarding ankylosing spondylitis by density-equalizing mapping and scientometric methods01--20078156Schoffel et al. ([@CR151])17.Vitzthum et al.2010Scientometric analysis and combined density-equalizing mapping of environmental tobacco smoke (ETS) research1900--20086580Vitzthum et al. ([@CR172])18.Zell et al.2010Air pollution research: visualization of research activity using density-equalizing mapping and scientometric benchmarking procedures1955--200626,253Zell et al. ([@CR184])19.Vitzthum et al.2010Cardiac insufficiency: a critical analysis of the current publication procedures under quantitative and qualitative aspects1900--200782,828Vitzthum et al. [@CR173]20.Mache et al.2010Alzheimer's Disease---a Scientometric Analysis and Data Acquisition1985--200850,030Mache et al. ([@CR110])21.Groneberg et al.2011Drowning-a scientometric analysis and data acquisition of a constant global problem employing density equalizing mapping and scientometric benchmarking procedures1900--20062381Groneberg et al. ([@CR74])22.Healy et al.2011The h index and the identification of global benchmarks for breast cancer research output1945--2008n.a.Healy et al. ([@CR86])23.Van Mark et al.2011Shift- and Nightwork---a scientometric analysis1900--20083092van Mark et al. ([@CR169])24.Vogelzang et al.2011Depression and suicide publication analysis, using density equalizing mapping and output benchmarking1900--20076069Vogelzang et al. ([@CR176])25.Glynn et al.2012Laryngeal cancer: quantitative and qualitative assessment of research output, 1945--20101945--20108658Glynn et al. ([@CR58])26.Vogelzang et al.2012A bibliometric analysis of bipolar affective disorders using density-equalizing mapping and output benchmarking1900--200818,831Vogelzang et al. ([@CR175])27.Bundschuh et al.2013Yellow fever disease: density equalizing mapping and gender analysis of international research output1900--20125053Bundschuh et al. ([@CR34])28.Fricke et al.2013Influenza: a scientometric and density-equalizing analysis1900--200951,418Fricke et al. ([@CR46])29.Gerber et al.2013Gout: a critical analysis of scientific development1990--20124424Gerber et al. ([@CR54])30.Groneberg-Kloft et al.2013Traffic medicine-related research: a scientometric analysis1900--20085193Groneberg-Kloft et al. ([@CR79])31.Schmidt et al.2014Hepatitis B: global scientific development from a critical point of view1971--201149,166Schmidt et al. ([@CR141])32.Addicks et al.2014MRSA: a density-equalizing mapping analysis of the global research architecture1961--20077671Addicks et al. ([@CR4])33.Carl et al.2014Curare-a curative poison: a scientometric analysis1900--20133867Carl et al. ([@CR38])34.Gerber et al.2014Antineutrophil cytoplasmic antibody-associated vasculitides: a scientometric approach visualizing worldwide research activity1993--20136216Gerber et al. ([@CR55])35.Mund et al.2014Global research on smoking and pregnancy-a scientometric and gender analysis1900-201210,043Mund et al. ([@CR119])36.Gerber et al.2014A scientometric analysis of global research activity during the last 35 years1972--201211,839Gerber et al. ([@CR56])37.Gerber et al.2014Silicosis: geographic changes in research: an analysis employing density-equalizing mapping1920--20122805Gerber et al. ([@CR57])38.Pleger et al.2014Bacterial meningitis: a density-equalizing mapping analysis of the global research architecture1900--20077998Pleger et al. ([@CR128])39.Brüggmann et al.2015Congenital toxoplasmosis: an in-depth density-equalizing mapping analysis to explore its global research architecture1900--201213,044Bruggmann et al. ([@CR23])40.Geaney et al.2015Type 2 Diabetes Research Yield, 1951-2012: Bibliometrics Analysis and Density-Equalizing Mapping1951--201224,783Geaney et al. ([@CR52])41.Brüggmann et al.2015Caesarean Section-A Density-Equalizing Mapping Study to Depict Its Global Research Architecture1900--201312,608Bruggmann et al. ([@CR27])42.Groneberg et al.2015Density equalizing mapping of obesity: analysis of a global epidemic1900--200994,987Groneberg et al. ([@CR70])43.Ohlendorf et al.2015Arthrosis: a scientometric analysis1900--201346,212Ohlendorf et al. ([@CR125])44.Groneberg et al.2015Telemedicine---a scientometric and density equalizing analysis1900--20063290Groneberg et al. ([@CR73])45.Quarcoo et al.2015Ebola and Its Global Research Architecture-Need for an Improvement1976--20143081Quarcoo et al. ([@CR133])46.Groneberg et al.2015Density equalizing mapping of the global tuberculosis research architecture1900--201258,319Groneberg et al. ([@CR75])47.Ohlendorf et al.2015Magnetic resonance imaging Density equalizing mapping analysis of global research architecture1981--200749,122Ohlendorf et al. ([@CR126])48.Brüggmann et al.2016Endometriosis and its global research architecture: an in-depth density-equalizing mapping analysis1900--200911,056Bruggmann et al. ([@CR22])49.Groneberg et al.2016Pancreatitis: Global Research Activities and Gender Imbalances: A Scientometric Approach Using Density-Equalizing Mapping1900--201227,826Groneberg et al. ([@CR68])50.Brüggmann et al.2016World-wide architecture of osteoporosis research: density-equalizing mapping studies and gender analysis1900--201257,453Bruggmann et al. ([@CR29])51.Köster et al.2016Rotavirus---Global research density equalizing mapping and gender analysis1900--20135906Koster et al. ([@CR100])52.Brüggmann et al.2016Global architecture of gestational diabetes research: density-equalizing mapping studies and gender analysis1900--201212,504Bruggmann et al. ([@CR31])53.Groneberg et al.2016Snakebite Envenoming---A Combined Density Equalizing Mapping and Scientometric Analysis of the Publication History1900--201617,998Groneberg et al. [@CR71]54.Schöffel et al.2016Ulcerative colitis: A scientometric approach to the global research output and network1900--201640,343Schoffel et al. ([@CR143])55.Schreiber et al.2016Patient safety: the landscape of the global research output and gender distribution1963--20144079Schreiber et al. ([@CR156])56.Schöffel et al.2016A critical perspective on the global research activity in the field of bladder cancer1900--200719,651Schoffel et al. ([@CR145])57.Groneberg et al.2016Analysis of the research architecture on the burnout syndrome1983--20063146Groneberg et al. [@CR72]58.Schöffel et al.2016Sarcoidosis: A Descriptive Approach to the Global Research Network and Recent Scientific Developments1900--200814,190Schoffel et al. ([@CR147])59.Groneberg-Kloft et al.2016Analysis of research architecture in the field of psychiatric rehabilitation1900--20099271Groneberg-Kloft et al. ([@CR78])60.Schöffel et al.2016Pancreatic Cancer-Critical Examination of the Global Research Architecture and Recent Scientific Developments1900--201311,445Schoffel et al. ([@CR148])61.Brüggmann et al.2017Polycystic ovary syndrome: analysis of the global research architecture using density equalizing mapping1900--20146261Bruggmann et al. ([@CR21])62.Groneberg et al.2017Glioblastoma research: US and international networking achievements1900--200814,411Groneberg et al. ([@CR67])63.Brüggmann et al.2017Ectopic pregnancy: exploration of its global research architecture using density-equalizing mapping and socioeconomic benchmarks1900--20128040Bruggmann et al. ([@CR25])64.Götting et al.2017Pulmonary Hypertension: Scientometric Analysis and Density-Equalizing Mapping1900--200718,986Gotting et al. ([@CR61])65.Brüggmann et al.2017Respiratory syncytial virus: a systematic scientometric analysis of the global publication output and the gender distribution of publishing authors1900--20134600Bruggmann et al. ([@CR26])66.Schöffel et al.2017Hirschsprung Disease: Critical Evaluation of the Global Research Architecture Employing Scientometrics and Density-Equalizing Mapping1900--20152978Schoffel et al. ([@CR146])67.Brüggmann et al.2017Ovarian cancer: density equalizing mapping of the global research architecture1900-201423,378Bruggmann et al. ([@CR30])68.Schöffel et al.2017Evaluation of the Global Research Architecture Regarding Diabetic Retinopathy1900--200815,624Schoffel et al. ([@CR153])69.Brüggmann et al.2017Maternal depression research: socioeconomic analysis and density-equalizing mapping of the global research architecture1900--20127330Bruggmann et al. ([@CR32])70.Groneberg2018Biomedical Research in Wroclaw: A Combined Density-Equalizing Mapping and Scientometric Analysis1972--201610,366Groneberg ([@CR64])71.Brüggmann et al.2018World-wide research architecture of vitamin D research: density-equalizing mapping studies and socio-economic analysis1900--201425,992Bruggmann et al. ([@CR20])72.Groneberg et al.2018The story behind Oncotarget? A bibliometric analysis2010--201721,961Groneberg et al. ([@CR69])73.Brüggmann et al.2018Human papilloma virus: global research architecture assessed by density-equalizing mapping1900--200929,330Bruggmann et al. ([@CR24])74.Klingelhöfer et al.2018Fifteen years after September 11: Where is the medical research heading? A scientometric analysis2001--20164250Klingelhofer et al. ([@CR96])75.Brüggmann et al.2018The uterine fibroid/myoma tumour: analysis of the global research architecture using density-equalizing mapping1900--20156176Bruggmann et al. ([@CR28])76.Groneberg2018Social sciences research in the Central European city of Wroclaw: A density-equalizing mapping analysis1966--20171787Groneberg ([@CR65])77.Lammer et al.2018Development of the global schizophrenia research under epidemiological and socio-economic influences1900--201542,492Lammer et al. ([@CR107])78.Trost et al.2018Immigration: analysis, trends and outlook on the global research activity1900--20166763Trost et al. ([@CR167])79.Klingelhöfer et al.2018Aflatoxin---Publication analysis of a global health threat1900--20065122Klingelhofer et al. ([@CR97])80.Schöffel et al.2018Crohn's Disease: A Critical Approach to Publication Procedures and Citation Behavior of the Global Research Network1900--201345,259Schoffel et al. ([@CR144])81.Trost et al.2018Immigration: analysis, trends and outlook on the global research activity1900--20166763Trost et al. ([@CR167])82.Groneberg2019Academic chemistry and related fields in Wroclaw: Density-equalizing mapping studies over the past decades1972--201615,267Groneberg ([@CR66])

Limitations of NewQIS {#Sec9}
---------------------

There are numerous limitations present in every NewQIS-based study:As with every other bibliometric approach, also NewQIS is limited to the data base it uses. Although producing global landscapes of research, it should never be forgotten that these pictures only delineate the research output which can be found in a specific data base (i.e. Web of Science) with a specific search term. Thus, all research not listed in the WoS and all research excluded by the search term (no search term can be absolutely perfect) is not included in the global landscape. This needs to be taken into account carefully when NewQIS results are interpreted. Especially the language bias constitutes an important problem: journals published in English have a higher chance of getting included to the data bases (Nieminen and Isohanni [@CR123]). Thus, non-English speaking countries are underrepresented concerning their research activities and important but regional data such as regional epidemiologic data is not identified (Pleger et al. [@CR128]).A further limitation that needs to be addressed is the above Matthew effect mentioned above: Communication systems in science are directed towards a reward of highly productive and renowned scientists and institutions. This leads to a pyramidal citation scheme (Merton [@CR114]; Pleger et al. [@CR128]).The so-called (semi-)qualitative indicators that are used in NewQIS are parameters such as the total citations, citation rate, country-specific h-index. They need to be interpreted very carefully. As already earlier critically discussed, they are not real measures for the quality of individual research (Pleger et al. [@CR128]). In this respect, a recent study addressed the question if methodological quality and completeness of reporting are associated with citation-based measures of publication impact (Mackinnon et al. [@CR111]). The authors performed a secondary analysis of a systematic review of dementia biomarker studies. They reported that citation rates and 5-year journal impact factors appear to measure different dimensions. While citation rates were weakly associated with completeness of reporting, none of these metrics was related to methodological rigor. They suggested that high publication usage and journal outlet is not a guarantee of quality and readers should critically appraise all papers regardless of presumed impact (Mackinnon et al. [@CR111]). Therefore, qualitative aspects are better addressed by advanced meta-analysis approaches using i.e. Cochrane systematics (Stovold et al. [@CR162]).

Further issues {#Sec10}
--------------

Scientometrics as research area is a niche within science. Funding is difficult to acquire for scientometric projects. However, it is the long term aim of NewQIS to analyze about 200 different areas within the next decade and to repeat assessments in 5- to 10-year intervals of important areas in order to assess changes in global research activities. When counting the raw data analyzed in the first 100 projects, we approximately invested about 50,000 work hours. Without extramural funding, this was only achievable by the workforce of medical students who performed their MD projects within NewQIS. In contrast to peer reviewed scientific reports which have been published for different NewQIS studies, a German medical thesis usually encompasses a much longer manuscript with 80--100 pages. This has been achieved by the medical students by writing comprehensive introductions about the field of research they analyze within their thesis. Thereby, they demonstrate that they possess an extensive knowledge about their thesis project. This is a prerequisite to obtain an MD degree. Also, the thesis students have to write detailed descriptions of their methodological approach (the NewQIS techniques) in the methods sections of the thesis and they have to discuss limits of the methodology in the discussion sections of their thesis.

This leads to two potential pitfalls:In the case of the methods sections, the thesis students have to follow strictly the above described protocols of NewQIS. This technical overlap is important and a strength of the platform in order to facilitate the comparison of results between the different diseases studied. However, it can be anticipated, that the use of these stringent protocols in nearly 80 different thesis projects---all with different target areas, i.e. ranging from burnout syndrome (Fröhlich [@CR48]) to bronchial asthma (Puk [@CR131])---brings the same problem as rewriting a passage on the methodology of other highly structured techniques such as RT-PCR (reverse transcriptase-polymerase chain reaction) which has now been published more than 250,000 times according to the PubMed. As with nearly identical descriptions of PCR and other molecular biology methods which can be found in peer reviewed scientific papers, an overlapping wording does not represent an act of plagiarism but rather exemplifies the impossibility to reword a similar methods section for more than 80 times without overlapping sentences. This does also apply for the part of the discussion in which the methodology and its limitations are discussed. Addressing these issues, the international Committee on Publication Ethics (COPE) points to a guideline of BioMed Central editors which outlines the following: "Use of similar or identical phrases in methods sections where there are limited ways to describe a common method, (...), is not uncommon. In such cases, an element of text recycling is likely to be unavoidable in further publications using the same method. Editors should use their discretion when deciding how much overlap of methods text is acceptable, considering factors such as whether authors have been transparent and stated that the methods have already been described in detail elsewhere and provided a citation" (COPE) (<https://publicationethics.org/text-recycling-guidelines>). Therefore, to overcome this pitfall, peer-reviewed NewQIS studies cite previous studies because of the methodological similarities---which are a strength of the platform. Also, thesis students are urged to cite every other NewQIS thesis which used the platform and to declare that the used methodology is part of NewQIS and therefore similar (apart from i.e. the different search terms).The introductions of the respective thesis usually follow the guidelines of up-to-date reviews i.e. on the disease which is analyzed for the thesis. In this respect, numerous introductions from NewQIS related thesis projects were also published as CME (continuing medical education) articles or as narrative reviews. Unfortunately, a recent analysis showed that within one thesis project, almost all parts of the introduction were copied by the student from the Wikipedia---a case of severe plagiarism that led to the deprivation of the Dr. med. degree (MD Thesis) of the student (Sudik [@CR163]). In order to prevent future cases of plagiarism, all medical thesis now need to be analyzed within a plagiarism check prior to the official submission of the thesis to the medical school.

Future of NewQIS {#Sec11}
================

The NewQIS platform will be used as NewQIS 2.0 in a next decade of further scientometric studies. There will be the following issues:

*Project of 200* As stated earlier, NewQIS 2.0 is intended to encompass about 200 different search projects with all areas of medicine, life sciences and also other areas of science in the next 10 years. Also, projects carried out 10 years ago and reported worldwide research activities (in the Web of Science) until 2005, should now be repeated in order to investigate the development of scientific activities.

*New focuses* Originally conceived as a tool to investigate publication activities in single areas of medicine, i.e. in different infectious diseases, NewQIS has also proven to be a valuable tool for other purposes, i.e. to analyze journals (Scutaru et al. [@CR159]; Groneberg et al. [@CR69]). Also, it could be used for the analysis of cities with regard to research activities of affiliations in these cities. A recent example was the so-called NewQIS-Wroclaw project that assessed scientific activities in the Central European Polish city in three different areas: biomedical research, chemical research and social sciences (Groneberg [@CR64], [@CR65], [@CR66]) and demonstrated a strong increase over the past decades.

*New parameters* As introduced in the past years, NewQIS studies may also focus upon socio-economic features. In this respect, various economic key figures were used. I.e. two quotients were calculated to assess the scientific output of a specific country for RSV research (Bruggmann et al. [@CR26]):in relation to the number of inhabitants (Q1)in relation to its economic power (as measured by the gross domestic product, GDP, Q2) (Bruggmann et al. [@CR26]). Data regarding the population and GDP of investigated countries was obtained from 2012 The quotients were calculated as follows:Articles/population index (Q1) = number of articles/population in million inhabitantsArticles/GDP index (Q2) = number of articles/GDP in 1000 billion US-Dollars

Within the RSV research NewQIS study, also, all countries were classified into high-income, upper-middle-income, lower-middle-income and low-income groups according to World Bank definitions (Bruggmann et al. [@CR26]). Then, the total number of RSV articles was related to the gross domestic expenditure on Research and Development (R&D in % of GDP) as well as to the number of researchers (per million inhabitants) affiliated to the investigated countries.

Conclusion {#Sec12}
==========

For over 10 years, the NewQIS platform has been used as a tool for peer reviewed scientific studies and for medical thesis in order to study numerous fields of science. As NewQIS 2.0 the project now heads into the next decade with a variety of new aspects in focus such as detailed socio-economic analysis or gender aspects. Using density equalizing mapping projections thousands of new pictures of global research landscapes will be generated. With numerous novel aspects that have been introduced to NewQIS within the past years, the platform will be a helpful tool for different aspects of scientometrics in the future.
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